Caterina Motta

Medicine & Life Sciences

1. Multiple Sclerosis 100%
2. Alzheimer Disease 57%
3. Cerebrospinal Fluid 45%
4. Autoimmune Experimental Encephalomyelitis 38%
5. Relapsing-Remitting Multiple Sclerosis 31%
6. Cannabinoid Receptor CB1 30%
7. Interleukin-1 30%
8. Stroke 29%
9. Long-Term Potentiation 28%
10. Cognitive Dysfunction 24%
11. Glutamic Acid 23%
12. Transcranial Magnetic Stimulation 23%
13. Natalizumab 18%
14. Cytokines 17%
15. Endocannabinoids 17%
16. Apolipoprotein E4 17%
17. Inflammation 17%
18. Amino Acid Transport System X-AG 16%
19. Neuronal Plasticity 16%
20. Astrocytes 15%
21. Genotype 15%
22. Thrombectomy 14%
23. Tumor Necrosis Factor-alpha 14%
24. Fatigue 14%
25. Neural Stem Cells 14%
26. Stem Cell Transplantation 13%
27. Glatiramer Acetate 13%
28. Anxiety 12%
29. Corpus Striatum 12%
30. Fingolimod Hydrochloride 11%
31. gamma-Aminobutyric Acid 11%
32. Brain 11%
33. Dementia 11%
34. Disease Progression 10%
35. Reperfusion 10%
36. Synaptic Transmission 10%
37. Psychological Inhibition 10%
38. Observational Studies 10%
39. Pyramidal Tracts 9%
40. TRPV1 receptor 9%
41. Therapeutics 9%
42. Memory 9%
43. Positron Emission Tomography Computed Tomography 9%
44. Amyloid 9%
45. Mental Status and Dementia Tests 8%
46. Interleukin-8 8%
47. Computed Tomography Angiography 8%
48. Drive 8%
49. Gait Analysis 8%
50. Cognitive Reserve 8%